Skip to main content

Assessment of Surveillance Test Performance and Cost

  • Chapter
Book cover The Bionic Human
  • 1339 Accesses

Abstract

Surveillance test performance and costs are important considerations for a book summarizing the state of the art in patient management after implantation of prosthetic devices for several reasons. First is the growing concern about more efficient use of limited resources, made ever more apparent by the ongoing health care reform debate. Second is the expanding role of “gatekeepers” wielding increasing control over the total cost of health care. Third is the push for clinicians to develop guidelines, driven by the idea that reimbursement could subsequently be tied to adherence to these guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mausner JS, Kramer S. Epidemiology—an introductory text (2nd ed.). Philadelphia, PA: W.B. Saunders, 1985.

    Google Scholar 

  2. Fisher LD, van Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley, 1993.

    Google Scholar 

  3. Benish WA. Graphic and tabular expressions of Bayes’ theorem. Med Decis Making 1987;7:104–106.

    Article  CAS  Google Scholar 

  4. Fagan TJ. Nomogram for Bayes’ formula. N Engl J Med 1975;293:257.

    CAS  Google Scholar 

  5. Matchar DB, Simel DL, Geweke JF, Feussner JR. A Bayesian method for evaluating medical test operating characteristics when some patients’ conditions fail to be diagnosed by the reference standard. Med Decis Making 1990;10:102–111.

    Article  CAS  Google Scholar 

  6. Irwig L, Glasziou PP, Berry G, Chock C, Mock P, Simpson JM. Efficient study designs to assess the accuracy of screening tests. Am J Epidemiol 1994;140:759–769.

    CAS  Google Scholar 

  7. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials (2nd ed.). Baltimore, MD: Williams & Wilkins, 1988.

    Google Scholar 

  8. Vecchio TJ. Predictive value of a single diagnostic test in unselected populations. N Engl J Med 1966;274:1171–1173.

    Article  CAS  Google Scholar 

  9. Friedman GD. Primer of epidemiology (2nd ed.). New York: McGraw-Hill Book, 1980.

    Google Scholar 

  10. Woolson RF. Statistical methods for the analysis of biomedical data. New York: John Wiley, 1987.

    Google Scholar 

  11. Knottnerus JA, Leffers P. The influence of referral patterns on the characteristics of diagnostic tests. J Clin Epidemiol 1992;45:1143–1154.

    Article  CAS  Google Scholar 

  12. Wilson JM, Jungner F. Principles and practice of screening for disease. Geneva: World Health Organization, Public Health Papers; 1968: No. 34.

    Google Scholar 

  13. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia, PA: W.B. Saunders, 1985.

    Google Scholar 

  14. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283–298.

    Article  CAS  Google Scholar 

  15. Sox HC, Blatt MA, Higgins HC, Marton KI. Medical decision making. Boston, MA: Butterworths, 1988.

    Google Scholar 

  16. Swets JA. Signal detection and recognition by human observers. New York: John Wiley, 1964.

    Google Scholar 

  17. Centor RM. Signal detectability: the use of ROC curves and their analysis. Med Decis Making 1991;11:102–106.

    Article  CAS  Google Scholar 

  18. van der Schouw YT, Straatman H, Verbeek AL. ROC curves and the areas under them for dichotomized tests: empirical findings for logistically and normally distributed diagnostic test results. Med Decis Making 1994;14:374–381.

    Article  Google Scholar 

  19. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29–36.

    CAS  Google Scholar 

  20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–843.

    CAS  Google Scholar 

  21. Metz CE, Kronman HB. Statistical significance tests for binormal ROC curves. J Math Psych 1980;22:218–243.

    Article  Google Scholar 

  22. Moise A, Clement B, Ducimetiere P, Bourassa MG. Comparison of receiver operating curves derived from the same population: a bootstrapping approach. Comput Biomed Res 1985;18:125–131.

    Article  CAS  Google Scholar 

  23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1985;44:837–845.

    Article  Google Scholar 

  24. McClish DK. Comparing the areas under more than two independent ROC curves. Med Decis Making 1987;7:149–155.

    Article  CAS  Google Scholar 

  25. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Boston, MA: Butterworths, 1988.

    Google Scholar 

  26. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Alhava E. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50, and CA 242 in pancreatic cancer: results from a prospective study. Br J Cancer 1993;67:852–855.

    CAS  Google Scholar 

  27. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980;302:1109–1117.

    Article  CAS  Google Scholar 

  28. Nease RF, Owens DK, Sox HC. Threshold analysis using diagnostic tests with multiple results. Med Decis Making 1989;9:91–103.

    Article  Google Scholar 

  29. Glasziou P. Threshold analysis via the Bayes’ nomogram. Med Decis Making 1991;11:61–62.

    Article  CAS  Google Scholar 

  30. Warner KE, Luce BR. Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor, MI: Health Administration Press, 1982.

    Google Scholar 

  31. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications, 1987.

    Google Scholar 

  32. Weinstein MC. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716–721.

    Article  CAS  Google Scholar 

  33. Dasgupta AK, Pearce DW. Cost-benefit analysis: theory and practice. London: Macmillan, 1972.

    Google Scholar 

  34. Mishan EJ. Cost-benefit analysis. London: George Allen and Unwin, 1975.

    Google Scholar 

  35. Sugden R, Williams AH. The principles of practical cost-benefit analysis. Oxford: Oxford University Press, 1979.

    Google Scholar 

  36. Eastaugh SR. Medical economics and health finance. Dover, MA: Auburn House, 1981.

    Google Scholar 

  37. Robinson R. Cost-utility analysis. BMJ 1993;307:859–862.

    CAS  Google Scholar 

  38. Strom BL. Pharmacoepidemiology. New York: Churchill Livingstone, 1989.

    Google Scholar 

  39. Rapoport J, Robertson RL, Stuart B. Understanding health economics. Rockville, MD:, 1982.

    Google Scholar 

  40. Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions. Med Care 1993;31:403–418.

    Article  CAS  Google Scholar 

  41. Muller A, Reutzel TJ. Willingness to pay for reduction in fatality risk: an exploratory survey. Am J Public Health 1984;74:808–812.

    CAS  Google Scholar 

  42. Zeckhauser R. Procedures for valuing lives. Public Policy 1975;23:419–464.

    CAS  Google Scholar 

  43. Jacobs P. The economics of health and medical care. Rockville, MD: Aspen, 1987.

    Google Scholar 

  44. Robinson R. Cost-benefit analysis. BMJ 1993;307(b):924–926.

    CAS  Google Scholar 

  45. Mehrez A, Gafni A. Quality adjusted life years and healthy year equivalents. Med Decis Making 1989;9:142–149.

    Article  CAS  Google Scholar 

  46. Mehrez A, Gafni A. Healthy-years equivalents versus quality-adjusted life years. Med Decis Making 1993;13:287–292.

    Article  CAS  Google Scholar 

  47. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chron Dis 1978;31:697–704.

    Article  CAS  Google Scholar 

  48. Patrick DL, Starks HE, Cain KC, Uhlmann, RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Making 1994;14:9–18.

    Article  CAS  Google Scholar 

  49. Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Socio Econ Plan Sci 1976;10:129–136.

    Article  Google Scholar 

  50. von Neumann J, Morgenstern O. Theory of games and economic behavior. New York: John Wiley,1953.

    Google Scholar 

  51. Sonnenberg FA. U-maker 1.0 [computer program]. Microcomputer utility assessment program. New Brunswick, NJ, 1993.

    Google Scholar 

  52. Gafni A. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res 1994;29:207–224.

    CAS  Google Scholar 

  53. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programmes. Health Serv Res 1972;7:118–133.

    CAS  Google Scholar 

  54. Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care 1990;6:93–103.

    Article  CAS  Google Scholar 

  55. Johannesson M, Pliskin JS, Weinstein MC. A note on QALYs, time trade-off, and discounting. Med Decis Making 1994;14:188–193.

    Article  CAS  Google Scholar 

  56. Carr-Hill R. Assumptions of the QALY procedure. Soc Sci Med 1989;29:469–477.

    Article  CAS  Google Scholar 

  57. Carr-Hill R. Allocating resources to health care: is the QALY a technical solution to a political problem? Int J Health Serv 1991;21:351–363.

    CAS  Google Scholar 

  58. Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med 1989;28:299–308.

    Article  CAS  Google Scholar 

  59. Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ 1991;10:21–41.

    Article  CAS  Google Scholar 

  60. Johannesson M, Pliskin JS, Weinstein MC. Are healthy-years equivalents an improvement over quality-adjusted life years. Med Decis Making 1993;13:281–286.

    Article  CAS  Google Scholar 

  61. Robinson R. Cost-effectiveness analysis. BMJ 1993;307(c):793–795.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Virgo, K.S. (2006). Assessment of Surveillance Test Performance and Cost. In: Johnson, F.E., Virgo, K.S., Lairmore, T.C., Audisio, R.A. (eds) The Bionic Human. Humana Press. https://doi.org/10.1007/978-1-59259-975-2_2

Download citation

Publish with us

Policies and ethics